Apogee Therapeutics, Inc. Common Stock Earnings Dividend
Earnings Summary
Net Profits | $-85.85Mn |
Apogee Therapeutics, Inc. Common Stock’s net profit fell -29.89% since last year same period to $-85.85Mn in the Q2 2026. On a quarterly growth basis, Apogee Therapeutics, Inc. Common Stock has generated -15.85% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.1 |
EPS Estimate Current Year | -1.1 |
Apogee Therapeutics, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -1.1 - a 2.65% jump from last quarter’s estimates.
Apogee Therapeutics, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -1.1.
Key Ratios
Earning Per Share (EPS) | -1.14 |
Apogee Therapeutics, Inc. Common Stock’s earning per share (EPS) fell -0.88% since last year same period to -1.14 in the Q2 2026. This indicates that the Apogee Therapeutics, Inc. Common Stock has generated -0.88% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-11 | -1.13 | -1.06 | 6.19% |
2026-08-10 | -1.1 | -1.14 | -3.64% |
